Radiomics Based on Multimodal Imaging in Predicting Staging and Prognosis of Pancreatic Cancer
1 other identifier
observational
300
0 countries
N/A
Brief Summary
Retrospectively analyzed radiomics features of pancreatic ductal adenocarcinoma to predict staging and prognosis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2010
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2020
CompletedFirst Submitted
Initial submission to the registry
June 29, 2021
CompletedFirst Posted
Study publicly available on registry
July 8, 2021
CompletedJuly 8, 2021
June 1, 2021
11 years
June 29, 2021
June 29, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
radiomics features
1409 radiomics features can be extracted from the images.
After sketching the ROI
Study Arms (2)
Positive lymph node metastasis
pathological diagnosis :Positive lymph node metastasis
Negative lymph node metastasis
pathological diagnosis :Negative lymph node metastasis
Interventions
Eligibility Criteria
Pancreatic tumor patients
You may qualify if:
- radical resection was performed, and histopathologically confirmed pancreatic ductal adenocarcinoma and lymph node status;2) CT and/or MRI enhancement examinations were performed 2 weeks before surgery;3) Patients with complete clinical data
You may not qualify if:
- (1)Patients who received radiotherapy or chemotherapy before preoperative imaging examination;2) Poor image quality.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Huishu Yuan
Peking University Third Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2021
First Posted
July 8, 2021
Study Start
January 1, 2010
Primary Completion
December 30, 2020
Study Completion
December 30, 2020
Last Updated
July 8, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share